OpenAlex
PricingAboutJobs
Log inGet started
Author

Qiangqiang Dai

Observed name: Q. Dai
Institution: Chengdu University of Traditional Chinese Medicine
Observed institutions: Sun Yat-sen University, University of Kansas Medical Center, The First Affiliated Hospital, Sun Yat-sen University, Chengdu University of Traditional Chinese Medicine
ORCID: 0009-0009-3977-1738
Observed ORCID: 0009-0009-3977-1738
OpenAlex ID: A5102998238
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicle in nonalcoholic fatty liver disease: a systematic review and meta-analysis of preclinical evidence
2025 · Qiangqiang Dai, Di Zhu, et al. · Lipids in Health and Disease · 9
PDF
P2.10A.05 Ipat-Lung: A Multi-Center Phase 2 Study of Ipatasertib Plus Docetaxel in NSCLC Patients who Have Failed or Are Intolerant to 1st Line Immunotherapy
2024 · J. Zhang, C.H. Huang, et al. · Journal of Thoracic Oncology · 2
PDF
98P Camrelizumab as neoadjuvant, first- or later-line treatment for non-small cell lung cancer (NSCLC): A retrospective real-world study (CTONG2004)
2021 · C. Xu, Q. Chen, et al. · Annals of Oncology · 2
Cumulative temporal association between assisted reproductive technology and childhood cancer: a systematic review and meta-analysis of observational studies
2025 · Yanjie Jiang, Qiangqiang Dai, et al. · Frontiers in Oncology · 1
PDF
Works count: 4
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security